Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Biosimilars Advisory Service : Physician Perspectives on Erythropoiesis-Stimulating Agents, Insulin, and Human Growth Hormone | US/EU5/Japan | 2015
Nephrologists and endocrinologists in Europe have had the opportunity to use biosimilar erythropoiesis-stimulating agents (ESAs) and human growth hormone (hGH), respectively, for several years, but…
Treatment Algorithms in Atrial Fibrillation | Treatment Algorithms | Claims Data Analysis | US | 2015
For the estimated 4.9 million people in the United States who suffer from atrial fibrillation (AF), there are a number of different treatment approaches that can be utilized, each with a wide range…
Monoclonal Antibodies for the Treatment and Prophylaxis of Infectious Diseases: Development Opportunities for Novel Antibacterial and Antiviral Biologics
The past two decades have seen the arrival of revolutionary new biologic therapies for the treatment of numerous diseases, including inflammatory, hematologic, and malignant conditions. The…
Hepatitis C Virus (Positioning of Current and Emerging HCV Regimens)| Physician & Payer Forum | Latin America | 2015
Tackling the Market Access Challenges in Brazil, Mexico, and Argentina Increases in seroprevalent cases of hepatitis C virus (HCV), disease awareness, and patient access to HCV treatment…
Wet Age-Related Macular Degeneration | Treatment Algorithms | Claims Data Analysis | US | 2015
Wet age-related macular degeneration (AMD) is characterized by abnormal growth of blood vessels under the retina, leading to optic nerve damage, visual impairment, and potentially blindness…
